SynthesisFrontiers in oncology2022

Efficacy and Safety Profile of Histone Deacetylase Inhibitors for Metastatic Breast Cancer: A Meta-Analysis.

Changjun Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.